Home Other Building Blocks 5-Bromonicotinic acid

5-Bromonicotinic acid

CAS No.:
20826-04-4
Catalog Number:
AG002JLT
Molecular Formula:
C6H4BrNO2
Molecular Weight:
202.0055
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$13
- +
25g
95%
In Stock USA
United States
$19
- +
100g
98%
In Stock USA
United States
$63
- +
250g
98%(HPLC)
In Stock USA
United States
$112
- +
500g
98%(HPLC)
In Stock USA
United States
$198
- +
Product Description
Catalog Number:
AG002JLT
Chemical Name:
5-Bromonicotinic acid
CAS Number:
20826-04-4
Molecular Formula:
C6H4BrNO2
Molecular Weight:
202.0055
MDL Number:
MFCD00009783
IUPAC Name:
5-bromopyridine-3-carboxylic acid
InChI:
InChI=1S/C6H4BrNO2/c7-5-1-4(6(9)10)2-8-3-5/h1-3H,(H,9,10)
InChI Key:
FQIUCPGDKPXSLL-UHFFFAOYSA-N
SMILES:
OC(=O)c1cc(Br)cnc1
EC Number:
244-065-5
NSC Number:
9461
Properties
Complexity:
140  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
200.943g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
202.007g/mol
Monoisotopic Mass:
200.943g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
50.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.1  
Literature
Title Journal
Exceptional crystallization diversity and solid-state conversions of Cd(II) coordination frameworks with 5-bromonicotinate directed by solvent media. Chemistry (Weinheim an der Bergstrasse, Germany) 20120924
2-(5-Bromo-pyridin-3-yl)-5-[3-(4,5,6,7-tetra-hydro-thieno[3,2-c]pyridine-5-ylsulfon-yl)thio-phen-2-yl]-1,3,4-oxa-diazole. Acta crystallographica. Section E, Structure reports online 20111001
Tetra-kis(μ-5-bromo-nicotinato)-κO,O':O';κO:O,O';κO:O'-bis-[diaqua-(5-bromo-nicotinato-κO,O')neodymium(III)] dihydrate. Acta crystallographica. Section E, Structure reports online 20110701
catena-Poly[[bis-(μ-5-bromo-pyridine-3-carboxyl-ato-κO:O')dicopper(II)]-bis-(μ-5-bromo-pyridine-3-carboxyl-ato)-κO,O':N;κN:O,O']. Acta crystallographica. Section E, Structure reports online 20101101
Poly[(μ(3)-5-bromo-nicotinato)(5-bromo-nicotinato)copper(II)]. Acta crystallographica. Section E, Structure reports online 20091001
catena-Poly[[(5-bromopyridine-3-carbox-yl-ato)dimetyltin(IV)]-μ-5-bromopyridine-3-carboxyl-ato]. Acta crystallographica. Section E, Structure reports online 20080101
Agonist lead identification for the high affinity niacin receptor GPR109a. Bioorganic & medicinal chemistry letters 20070901
Unusual sterically controlled regioselective lithiation of 3-bromo-5-(4,4'-dimethyl)oxazolinylpyridine. Straightforward access to highly substituted nicotinic acid derivatives. Organic letters 20061221
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET. Nuclear medicine and biology 20050801
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. European journal of pharmacology 20020125
Properties